Biomedical Engineering in Delaware

📊 Employment Overview

Delaware employs 57 biomedical engineering professionals, representing approximately 0.3% of the national workforce in this field. Delaware ranks #43 nationally for biomedical engineering employment.

💰 Salary Information

Biomedical Engineering professionals in Delaware earn competitive salaries across all experience levels, with an average annual salary of $102,000.

Note: Salaries are adjusted for cost of living and local market conditions. Data based on BLS statistics and industry surveys (2024-2025).

🎓 Schools Offering Biomedical Engineering

Loading school data...

🚀 Career Insights

Key information for biomedical engineering professionals in Delaware.

🏢 Industry Landscape & Top Employers

Delaware's biomedical engineering sector is small in absolute terms — 57 employed professionals ranking the state #43 nationally — but benefits from the state's unique geographic position in the heart of the Mid-Atlantic pharmaceutical and biomedical corridor. Delaware's proximity to Philadelphia's world-class medical and pharmaceutical ecosystem means that engineers based in the state often have access to a de facto employment market far larger than Delaware's borders suggest.

Major Employers: AstraZeneca's North American headquarters in Wilmington is the state's most prominent pharmaceutical-biomedical employer, with engineering roles spanning formulation devices, drug-device combination products, and manufacturing systems. Incyte Corporation (Wilmington), a leading oncology-focused biopharmaceutical company, employs biomedical and pharmaceutical engineers supporting clinical research and manufacturing processes. ChristianaCare (formerly Christiana Care Health System) — one of the largest health systems in the Mid-Atlantic — is Delaware's primary clinical engineering employer, with a nationally recognized Level I Trauma Center and an active Heart & Vascular Center that drives demand for specialized biomedical equipment engineers. Nemours Children's Health and Bayhealth Medical Center provide additional clinical engineering employment.

Key Industry Clusters: Wilmington is Delaware's economic and biomedical hub, anchored by AstraZeneca and a growing number of pharma service companies. The Wilmington-Newark corridor benefits from the University of Delaware's growing biomedical engineering program, which serves as the primary talent pipeline. ChristianaCare's hospital campuses in Newark and Wilmington anchor the clinical engineering employer cluster. Delaware's tax-advantaged corporate environment — the state is home to over 65% of Fortune 500 companies due to its corporation-friendly legal structure — creates a significant number of corporate healthcare technology positions even if the underlying operations are elsewhere.

Philadelphia Proximity: Engineers in Delaware have practical access to one of the strongest biomedical engineering ecosystems in the nation — the Philadelphia metro. Drexel University, Temple, Thomas Jefferson, Penn, and Children's Hospital of Philadelphia all have strong biomedical programs and employer networks that Delaware engineers can access. Many Delaware residents hold positions with Philadelphia-area employers without formally relocating, making Delaware's effective market significantly larger than its employment statistics suggest.

📈 Career Growth & Pathways

Delaware biomedical engineering careers are characterized by above-average salaries (driven by pharma industry influence), stable institutional employers, and the unique advantage of Mid-Atlantic market access without the full cost-of-living burden of Philadelphia or the Northeast's major metros.

• Entry-Level Engineer (0–2 years): $63,000–$76,000 — Clinical engineering associate at ChristianaCare, quality engineering at AstraZeneca's Wilmington facility, or research support roles at University of Delaware biomedical labs. The University of Delaware's co-op program creates strong pathways to local employer entry-level roles.
• Mid-Level Engineer (3–7 years): $85,000–$108,000 — Clinical technology specialist at ChristianaCare, pharmaceutical engineering lead at AstraZeneca or Incyte, or project engineering roles at contract research organizations with Delaware offices.
• Senior Engineer (8–14 years): $120,000–$147,000 — Clinical engineering director at Delaware health systems, senior pharmaceutical engineering roles, or independent consulting serving the Mid-Atlantic pharma-biomedical corridor.
• Principal / Director (15+ years): $150,000–$190,000 — Engineering directors at AstraZeneca's Wilmington operations, health system technology executives, or senior faculty at the University of Delaware's biomedical engineering department.

Cross-Market Career Strategy: Delaware engineers who develop expertise in FDA regulatory affairs, pharmaceutical manufacturing systems, or clinical informatics can access positions across the broader Mid-Atlantic corridor (Philadelphia, Baltimore, Washington DC) without relocating, given the region's dense employer network and manageable driving distances. This geographic flexibility is a significant career advantage unique to Delaware's location.

💰 Salary vs. Cost of Living

Delaware's $102,000 average biomedical engineering salary reflects the pharma industry's above-average compensation, and is paired with a cost of living that is notably lower than neighboring Mid-Atlantic metros — particularly Philadelphia and Washington DC. The state's famous lack of state sales tax provides an additional financial benefit.

Wilmington Metro: Delaware's urban center, where pharma and clinical engineering salaries are highest. Cost of living is approximately 15–22% above the national average — significantly below Philadelphia (25–30% above) and DC (35–45% above). Median home prices in Wilmington range from $240,000 to $380,000, with suburban communities (Hockessin, Greenville, Pike Creek) offering larger homes in the $350,000–$500,000 range that remain considerably more affordable than comparable Philadelphia suburbs.

No State Sales Tax: Delaware's absence of sales tax is a genuine financial benefit, particularly for large purchases — cars, electronics, and appliances. For engineers, this represents $2,000–$5,000 in annual savings compared to high-sales-tax states, a meaningful supplement to base compensation.

Lower Income Tax than Neighbors: Delaware's income tax (graduated rates, top rate 6.6%) is lower than Maryland (top 5.75% plus local taxes), Pennsylvania (3.07% flat plus local earned income taxes), and New Jersey (top 10.75%). Net of all state and local taxes, Delaware engineers often take home more of their gross salary than their counterparts earning comparable wages in neighboring states.

Pharma Industry Premium: AstraZeneca and Incyte pay pharmaceutical-industry compensation — meaningfully above what hospital-system or academic employers pay for comparable engineering roles. Senior biomedical engineers at major pharma companies in Wilmington can earn $130,000–$175,000 in total compensation, reflecting the global pharmaceutical industry's pay scale rather than the regional healthcare market's norms.

📜 Licensing & Professional Development

Delaware's engineering licensure is administered by the Delaware Association of Professional Engineers. The state has a straightforward, well-organized licensure process and full NCEES reciprocity, making it easy for engineers to transfer licenses from other states or use Delaware licensure as a foundation for multi-state practice across the Mid-Atlantic region.

Delaware PE Licensure Path:

• FE Exam: Required first step. University of Delaware's biomedical and related engineering programs produce qualified candidates. Delaware has a smaller engineering licensing community than neighboring states, which can sometimes speed administrative processing times.
• 4 Years of Progressive Experience: Under PE supervision. Delaware accepts a broad range of qualifying experience, including clinical engineering, pharmaceutical manufacturing engineering, and research roles.
• PE Exam: Delaware accepts the national PE exam through NCEES and offers full reciprocity with all NCEES member states — making it practical for engineers to build a multi-state license portfolio to cover the Mid-Atlantic corridor.

Pharmaceutical Engineering Qualifications: For engineers at AstraZeneca and Incyte, the American Institute of Chemical Engineers (AIChE) offers credentials relevant to pharmaceutical manufacturing and process engineering. ICH (International Council for Harmonisation) guidelines knowledge is expected for engineers involved in drug-device combination product development — AstraZeneca's inhaler and injection device programs require this expertise.

CCE / CBET: ChristianaCare values clinical engineering credentials and actively supports employee certification. The hospital system has one of the more sophisticated clinical engineering departments in the Mid-Atlantic for a non-academic medical center, with a professional development culture that prioritizes credential attainment.

📊 Job Market Outlook

Delaware's biomedical engineering market is stable with moderate growth potential, driven primarily by AstraZeneca's ongoing investment, ChristianaCare's expanding regional health system footprint, and the broader Mid-Atlantic life sciences ecosystem's positive trajectory.

AstraZeneca's Delaware Commitment: Despite global pharma industry consolidation, AstraZeneca has maintained and gradually expanded its Wilmington presence. The company's oncology and rare disease pipeline — driven by Incyte collaboration and proprietary research — requires ongoing engineering support for clinical trial device systems, combination product development, and manufacturing process innovation. Engineering employment at AstraZeneca's Delaware campus is expected to remain stable with modest growth tied to pipeline progression.

ChristianaCare's Regional Expansion: ChristianaCare has emerged as one of the Mid-Atlantic's most innovative health systems, receiving national recognition for clinical quality. The system's ongoing investment in cardiovascular, cancer, and orthopedic care technology — combined with new facility development — is creating sustained demand for clinical engineering talent. ChristianaCare's partnership with Christiana Care Health Innovations — an internal innovation lab focused on digital health and connected devices — may create novel engineering positions at the intersection of clinical and technology development.

University of Delaware Research: UD's growing biomedical engineering research enterprise, with NSF and NIH-funded programs in biomaterials, neural engineering, and regenerative medicine, is strengthening Delaware's position as a knowledge center rather than purely a service delivery market. Research commercialization through UD's technology transfer office may seed new Delaware-based device companies over the coming decade.

5-Year Projection: Delaware's biomedical engineering employment is projected to grow 8–12% over five years, representing approximately 5–7 net new positions in a small market. Pharmaceutical engineering and clinical informatics are the most likely growth areas.

🕐 Day in the Life

Biomedical engineering in Delaware benefits from a compact geography — the state is small enough that most engineers can access any employer within a 45-minute drive — and a work culture that blends Mid-Atlantic professionalism with more relaxed suburban rhythms than Philadelphia or DC.

At AstraZeneca (Wilmington): A pharmaceutical engineer's day at AstraZeneca reflects the global company's disciplined, process-oriented culture. Mornings often begin with cross-functional team meetings on combination product development timelines — coordinating engineering, regulatory affairs, and manufacturing representatives on a new inhaler device or auto-injector platform. Mid-day is typically spent in the lab — running design verification tests, reviewing material compatibility data, or preparing technical documentation for an FDA pre-submission meeting. Afternoons may involve regulatory strategy sessions with global teams across AstraZeneca's Gaithersburg, Cambridge (UK), and Gothenburg offices, reflecting the international scope of pharmaceutical device engineering.

At ChristianaCare (Newark/Wilmington): Clinical engineers at ChristianaCare operate in a high-performing health system environment where efficiency and patient safety drive every decision. A morning might involve completing routine preventive maintenance on ventilators, attending a multidisciplinary rounds meeting where a new therapeutic device is being discussed, and troubleshooting an alarm issue with infusion pumps in the cardiac care unit. Afternoons often involve capital planning work — ChristianaCare's significant clinical technology investments require detailed financial modeling and vendor analysis from its engineering team.

Lifestyle: Delaware engineers enjoy excellent quality of life at a lower cost than virtually all neighboring Mid-Atlantic metros. Wilmington's downtown is walkable and has a growing restaurant and arts scene. The Brandywine Valley — straddling Delaware and Pennsylvania — offers world-class museums (Brandywine River Museum, Hagley Museum), hiking, and the extraordinary Longwood Gardens. Delaware's beaches (Rehoboth, Dewey, Bethany) are accessible within 90 minutes, and Philadelphia's cultural offerings are 30 minutes north. The state is genuinely underrated as a quality-of-life destination for professionals who want proximity to major metros without the full cost premium.

🔄 Compare with Other States

See how Delaware compares to other top states for biomedical engineering: